BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2667106)

  • 1. Overview of Scandinavian in vitro studies with ciprofloxacin.
    Forsgren A
    Scand J Infect Dis Suppl; 1989; 60():16-22. PubMed ID: 2667106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
    Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
    Kayser FH; Novak J
    Am J Med; 1987 Apr; 82(4A):33-9. PubMed ID: 3555058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
    Debbia E; Schito GC; Nicoletti G; Speciale A
    Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W; Focht J; Nösner K
    Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin.
    Gould IM; Milne K; Jason C
    Drugs Exp Clin Res; 1990; 16(12):621-8. PubMed ID: 2130004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.
    Zeiler HJ; Petersen U; Gau W; Ploschke HJ
    Arzneimittelforschung; 1987 Feb; 37(2):131-4. PubMed ID: 3555512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of ciprofloxacin and other unrelated antimicrobials against bacterial respiratory tract pathogens.
    Felmingham D; Robbins MJ; Baskerville AJ; Sanghrajka MD; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1989; 15(2):59-62. PubMed ID: 2737080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of ciprofloxacin administered intravenously in a pharmacodynamic in vitro model.
    Esposito S; Jansen A
    Int J Clin Pharmacol Res; 1991; 11(4):193-9. PubMed ID: 1813438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ciprofloxacin against gram-positive cocci.
    Barry AL; Jones RN
    Am J Med; 1987 Apr; 82(4A):27-32. PubMed ID: 3578323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of in vitro activity of ciprofloxacin and pefloxacin against strains isolated from clinical material].
    Kumelj M; Rus A; Music E
    Plucne Bolesti; 1989; 41(3-4):193-5. PubMed ID: 2636406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerobic bacteria isolated from blood cultures of patients and their antibiotic susceptibilities in Harare, Zimbabwe.
    Obi CL; Mazarura E
    Cent Afr J Med; 1996 Dec; 42(12):332-6. PubMed ID: 9164012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-antibiotic effect of three quinolones against gram negative isolates from urine.
    Alados JC; Gutierrez J; Garcia F; Liebana J; Piedrola G
    Med Lab Sci; 1990 Oct; 47(4):272-7. PubMed ID: 2283929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
    Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
    Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-antibacterial effect of thymol.
    Zarrini G; Delgosha ZB; Moghaddam KM; Shahverdi AR
    Pharm Biol; 2010 Jun; 48(6):633-6. PubMed ID: 20645735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of ciprofloxacin and sixteen other antimicrobial agents against blood culture isolates.
    Eltahawy AT
    J Chemother; 1993 Apr; 5(2):94-102. PubMed ID: 8515299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect.
    Zhanel GG; Crampton J; Kim S; Nicolle LE; Davidson RJ; Hoban DJ
    Chemotherapy; 1992; 38(6):388-94. PubMed ID: 1288962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.